AI regulation lags despite entering higher- risk patient care | PharmaVoice
AI regulation lags despite entering higher- risk patient care. While more pharma companies launch DTC platforms, states, not the federal government, ...
Read the original at PharmaVoice ↗
- Topics
- HealthcareRegulation & PolicyGovernment & Public Sector
- Tracked via
- “AI Risks”